An assessment by the Statin Intolerance Panel: 2014 update.

Published

Journal Article

This article from the National Lipid Association Statin Intolerance Panel provides a framework for understanding statin intolerance and makes general recommendations for health professionals. For specific guidance on adverse events related to muscle, liver, cognition, and glucose metabolism, one should refer to the other reports of the Statin Safety Task Force for those topics. Although statin adverse effects rarely lead to permanent sequelae, symptomatic intolerance frequently hinders cardiovascular risk reduction by statins. We emphasize here the advisory role of the clinician helping each patient to make personal decisions on statin tolerability. We identify a pressing need for further research on statin intolerance and make suggestions for research design.

Full Text

Duke Authors

Cited Authors

  • Guyton, JR; Bays, HE; Grundy, SM; Jacobson, TA; The National Lipid Association Statin Intolerance Panel,

Published Date

  • May 2014

Published In

Volume / Issue

  • 8 / 3 Suppl

Start / End Page

  • S72 - S81

PubMed ID

  • 24793444

Pubmed Central ID

  • 24793444

International Standard Serial Number (ISSN)

  • 1933-2874

Digital Object Identifier (DOI)

  • 10.1016/j.jacl.2014.03.002

Language

  • eng

Conference Location

  • United States